1887
Volume 2024, Issue 1
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Anemia in kidney transplant recipients can stem from a diverse array of etiologies, including dietary deficiencies, inflammatory processes, allograft dysfunction, as well as viral and bacterial infections. We present a case of refractory anemia in a 49-year-old male patient occurring within the initial month following a kidney transplant, which persisted despite numerous transfusions, posing a formidable challenge. The patient was maintained on the standard immunosuppressant regimen—Tacrolimus, Mycophenolate, and Prednisolone. Diagnostic evaluations eliminated well-established causes such as dietary deficiencies, gastrointestinal losses, and prevalent infections. Subsequently, after viral PCR testing, a diagnosis of Pure Red Cell Aplasia (PRCA) due to infection with parvovirus B19 was made. Although the patient had a reduction in the immunosuppression drugs and received a course of Intravenous Immunoglobulins (IVIG) on two separate occasions spanning two months, the anemia relapsed. Subsequently, after an additional dose of IVIG with further modification and reduction of the immunosuppressant regimen, including stopping the mycophenolate and switching tacrolimus with cyclosporine, the patient ultimately achieved successful resolution of his symptoms and a significant decrease in viral load. Our case highlights the significance of unconventional etiologies when confronted with anemia in the setting of kidney transplantation. Furthermore, it also provides further insights into therapeutic avenues for addressing PRCA in kidney transplant recipients.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2024.8
2024-02-13
2024-07-21
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2024/1/qmj.2024.8.html?itemId=/content/journals/10.5339/qmj.2024.8&mimeType=html&fmt=ahah

References

  1. Shibagaki Y, Shetty A. Anaemia is common after kidney transplantation, especially among African Americans. Nephrol Dial Transplant. 2004 Sep; 19:(9):2368-73. doi: [Crossref].
    https://doi.org/10.1093/ndt/gfh256 [Google Scholar]
  2. Eisenga MF, Minović I, Berger SP, Kootstra-Ros JE, van den Berg E, Riphagen IJ, et al.. Iron deficiency, anemia, and mortality in renal transplant recipients. Transpl Int. 2016 Nov; 29:(11):1176-1183. doi: [Crossref].
    https://doi.org/10.1111/tri.12821 [Google Scholar]
  3. Schechter A, Gafter-Gvili A, Shepshelovich D, Rahamimov R, Gafter U, Mor E, et al.. Post renal transplant anemia: severity, causes and their association with graft and patient survival. BMC Nephrol. 2019 Feb 13; 20:(1):51. doi: [Crossref].
    https://doi.org/10.1186/s12882-019-1244-y [Google Scholar]
  4. Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet. 1975 Jan 11; 1:(7898):72-3. doi: [Crossref].
    https://doi.org/10.1016/s0140-6736(75)91074-0 [Google Scholar]
  5. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev. 2002 Jul; 15:(3):485-505. doi: [Crossref].
    https://doi.org/10.1128/CMR.15.3.485-505.2002 [Google Scholar]
  6. Barzon L, Murer L, Pacenti M, Biasolo MA, Della Vella M, Benetti E, et al.. Investigation of intrarenal viral infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury. J Infect Dis. 2009 Feb 1; 199:(3):372-80. doi: [Crossref].
    https://doi.org/10.1086/596053 [Google Scholar]
  7. Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, et al.. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int. 2001 Jun; 59:(6):2126-33. doi: [Crossref].
    https://doi.org/10.1046/j.1523-1755.2001.00727.x [Google Scholar]
  8. Ardalan MR, Shoja MM, Tubbs RS, Esmaili H, Keyvani H. Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus b19 infection. Am J Transplant. 2008 Jun; 8:(6):1340-4. doi: [Crossref].
    https://doi.org/10.1111/j.1600-6143.2008.02244.x [Google Scholar]
  9. Ki CS, Kim IS, Kim JW, Lee NY, Kim SH, Lee KW, et al.. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients. Clin Transplant. 2005 Dec; 19:(6):751-5. doi: [Crossref].
    https://doi.org/10.1111/j.1399-0012.2005.00415.x [Google Scholar]
  10. Park JB, Kim DJ, Woo SY, Choi GS, Chun JM, Jung GO, et al.. Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study. Transpl Int. 2009 Apr; 22:(4):455-62. doi: [Crossref].
    https://doi.org/10.1111/j.1432-2277.2008.00818.x [Google Scholar]
  11. Hai An HP, Diem HT, Cuong NT. Parvovirus B19-Associated Anemia in Kidney Transplant Recipients: A Single-Center Experience. Transplant Proc. 2019 Oct; 51:(8):2693-2696. doi: [Crossref].
    https://doi.org/10.1016/j.transproceed.2019.03.076 [Google Scholar]
  12. Pabisiak K, Stępniewska J, Ciechanowski K. Pure Red Cell Aplasia After Kidney Transplantation: Parvovirus B19 Culprit or Coincidence? Ann Transplant. 2019 Mar 5; 24::123-131. doi: [Crossref].
    https://doi.org/10.12659/AOT.913663 [Google Scholar]
  13. Egbuna O, Zand MS, Arbini A, Menegus M, Taylor J. A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature. Am J Transplant. 2006 Jan; 6:(1):225-31. doi: [Crossref].
    https://doi.org/10.1111/j.1600-6143.2005.01139.x [Google Scholar]
  14. Eid AJ, Ardura MI; AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019 Sep; 33:(9):e13535. doi: [Crossref].
    https://doi.org/10.1111/ctr.13535 [Google Scholar]
  15. Bentata Y. Parvovirus B19 in kidney transplantation: key points and essential pitfalls to know. Infect Dis (Lond). 2021 Jun; 53:(6):404-408. doi: [Crossref].
    https://doi.org/10.1080/23744235.2021.1893379 [Google Scholar]
  16. Ritter ML, Pirofski L. Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity. Transpl Infect Dis. 2009 Aug; 11:(4):290-7. doi: [Crossref].
    https://doi.org/10.1111/j.1399-3062.2009.00407.x [Google Scholar]
  17. Altheaby A, Alotaibi M, Alajlan N, Alshareef A, Alruwaymi M, Aboalsamh G, et al.. Parvovirus B19 Infection due to over Immunosuppression in Kidney Transplant Recipients: Case Reports and Literature Review. Case Rep Transplant. 2021 Nov 29; 2021::7651488. doi: [Crossref].
    https://doi.org/10.1155/2021/7651488 [Google Scholar]
  18. Geetha D, Zachary JB, Baldado HM, Kronz JD, Kraus ES. Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant. 2000 Dec; 14:(6):586-91. doi: [Crossref].
    https://doi.org/10.1034/j.1399-0012.2000.140612.x [Google Scholar]
  19. Krishnan P, Ramadas P, Rajendran PP, Madhavan P, Alex A, Jayaschandran V, et al.. Effects of Parvovirus B19 Infection in Renal Transplant Recipients: A Retrospective Review of Three Cases. Int J Angiol. 2015 Jun; 24:(2):87-92. doi: [Crossref].
    https://doi.org/10.1055/s-0034-1371759 [Google Scholar]
/content/journals/10.5339/qmj.2024.8
Loading
/content/journals/10.5339/qmj.2024.8
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error